ARCHIVES

FDA Approves Kytril For Post-Operative Nausea

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady Wins RSNA Medal

January 5, 1990

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

August 31, 2012

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

ASCO Recommends End of Life Discussions

January 28, 2011

Funding Opportunities: Lymphoma Fellowship

June 8, 2001